https://www.7hillspharma.com/news-publications
daily
0.75
2025-02-26
https://www.7hillspharma.com/news-publications/7-hills-pharma-safely-doses-first-patient-in-phase-1b2a-clinical-trial-testing-alintegimod-against-apd-1-resistant-solid-tumors
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/7-hills-pharma-receives-47mm-grant-to-advance-first-in-class-cellgene-therapy-technology-into-the-clinic
monthly
0.5
2025-02-26
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/1edd08e9-add1-4d49-be24-9e966391a306/7HP-Blog-20240603-1.jpg
News & Publications - 7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the Clinic
CCBC laboratory staff members prepare the Center’s 800th umbilical cord blood unit for shipment. 7 Hills Pharma aims to increase clinical utilization of cord blood resources and improve patient access to life-saving HSCT.
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/3a9e5f62-7c10-4f4a-bd21-8fd9b5eeb1ca/7HP-Blog-20240603-2.jpg
News & Publications - 7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the Clinic
Dr. Peter Vanderslice is a co-founder of 7 Hills Pharma and a pioneer of small molecule integrin activation.
https://www.7hillspharma.com/news-publications/7-hills-pharma-surpasses-25mm-milestone-in-nondilutive-funding
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/7-hills-pharma-receives-3mm-sbir-grant-from-niaid-to-accelerate-novel-vaccine-combination-against-chagas-disease
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/mjsb0sd7slo68uwj4t5e8vypgrcfdl
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/new-study-demonstrates-integrin-activation-can-bring-the-heat-to-cold-melanoma-tumors
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-5ejxt-mh6h4-h9jx9-nrm6w-a5znz-nnllp
monthly
0.5
2025-02-18
https://www.7hillspharma.com/news-publications/7hp-clinical-stage-novel-immunostimulant-granted-fda-fast-track-designation-for-anti-pd-1-resistant-metastatic-melanoma
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/gcaayri38qlf774iftmz5vev9jzgu5
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/texas-heart-institute-university-of-texas-medical-branch-utmb-and-7-hills-pharma-pioneer-significant-vaccine-research
monthly
0.5
2025-02-26
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/1738190181883-CUI803MWVFEHPJGUB6GK/7HP-Blog-20210914-2.jpg
News & Publications - Texas Heart Institute, University of Texas Medical Branch (UTMB) and 7 Hills Pharma Pioneer Significant Vaccine Research
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/1738190181891-VS6XJENNL2IR4N0DRKQO/7HP-Blog-20210914-1.jpg
News & Publications - Texas Heart Institute, University of Texas Medical Branch (UTMB) and 7 Hills Pharma Pioneer Significant Vaccine Research
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-5ejxt-mh6h4-h9jx9-nrm6w-a5znz
monthly
0.5
2025-02-18
https://www.7hillspharma.com/news-publications/yvfb1zav6rryz6sx17n8egvjp9zlf7
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-5ejxt-mh6h4-h9jx9-nrm6w
monthly
0.5
2025-02-18
https://www.7hillspharma.com/news-publications/immune-activators-enhancing-cell-adhesion-to-safely-improve-effectiveness-of-vaccines-amp-cancer-immunotherapies
monthly
0.5
2025-02-26
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/7669edd8-3d2e-465e-a858-57b2a1dc51e5/7HP-Blog-202103-1.jpg
News & Publications - IMMUNE ACTIVATORS – Enhancing Cell Adhesion to Safely Improve Effectiveness of Vaccines & Cancer Immunotherapies - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/0ef19a27-c944-420c-8c0a-ec39acf246c9/7HP-Blog-202103-2.jpg
News & Publications - IMMUNE ACTIVATORS – Enhancing Cell Adhesion to Safely Improve Effectiveness of Vaccines & Cancer Immunotherapies - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/716b9629-608a-49d6-9297-b4b851c36c98/7HP-Blog-202103-3.jpg
News & Publications - IMMUNE ACTIVATORS – Enhancing Cell Adhesion to Safely Improve Effectiveness of Vaccines & Cancer Immunotherapies - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/dfc34261-4f6e-4b31-95f1-866d3fbabe63/7HP-Blog-202103-4.jpg
News & Publications - IMMUNE ACTIVATORS – Enhancing Cell Adhesion to Safely Improve Effectiveness of Vaccines & Cancer Immunotherapies - Dr. Siddhartha De
Dr. Siddhartha De is a pharmacologist by training and is the Senior Director of Development at 7 Hills Pharma, where he has been deeply involved with the preclinical development of 7HP349 and its preparation for clinical readiness. He earned his PhD in Biochemistry in 2001 from the University of Mississippi School of Medicine, during which he elucidated the role of different H1 histone variants in the architecture of chromatin in the cell nucleus, and the functional consequence of this chromatin organization on nuclear processes, such as transcription, replication, and recombination. After his PhD, he worked at the University of Virginia for his post-doctoral research work, where he focused on the role of estrogen and androgen receptors in cancer, and at Luna Innovations to kick-start different Department of Defense (DoD)-funded programs to address homeland defense and counter bioterrorism. For the next several years, he worked for the drug discovery and development operations at Eurofins Advinus, where he headed in vitro Discovery Biology and the CNS therapeutic area, and led several programs to clinical candidacy. Additionally, he has worked in Project Management and Business Development, representing outlicensing strategy, partnerships, and contract services.
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/ca8e4c77-e3ca-49db-afb4-bf5a553e776a/7HP-Blog-202103-5.jpg
News & Publications - IMMUNE ACTIVATORS – Enhancing Cell Adhesion to Safely Improve Effectiveness of Vaccines & Cancer Immunotherapies - Dr. Peter Vanderslice
Dr. Peter Vanderslice is the Director, Biology of the Molecular Cardiology Research Laboratory at the Texas Heart Institute in Houston, TX, and is a 7 Hills Pharma Co-founder, investor, and an inventor of the company’s technology. He has spent over 25 years leading teams focused on the development of small molecule compounds that bind and modulate the function of integrins, selectins, and chemokine receptors. He has authored numerous peer-reviewed publications, reviews, and book chapters focusing on the biological function and therapeutic targeting of cell adhesion molecules. Much of his professional career has been in the pharmaceutical industry, where he gained extensive experience with each stage of the pipeline from discovery to progression into clinical trials. As Senior Director of Drug Discovery at Encysive Pharmaceuticals, he led teams developing therapeutics for autoimmune and inflammatory diseases. Three such programs resulted in compounds entering clinical trials. He joined the Texas Heart Institute in 2008 and has continued to discover and characterize integrin-targeted small molecules as potential therapeutics. These include a family of integrin activators, licensed to 7 Hills Pharma, that function as immune stimulants. He earned his PhD in Biochemistry from the University of Texas at Austin and trained as a Parker B. Francis post-doctoral fellow in the Cardiovascular Research Institute at the University of California, San Francisco.
https://www.7hillspharma.com/news-publications/two-incentives-that-could-open-the-floodgates-to-drug-repositioning-for-covid-19
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/236mubs8nuqnuvpc9zh1ebwds5bdoe
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/lft5wu52d577yroxl9zyio1hbeeyke
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/i167b29uqw1w7akhcuzhiz1j36y9tn
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/dar4bnqm5rfstxxd0w8vcphkmzx3ku
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/a1mo4zknvl606tzo6qapmv76s792vf
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/sz1kmzx6w770lopmdwylxoiuv4vias
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/4b99hxmhn1ewysntv4jbgzvjssgwwl
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-5ejxt-mh6h4
monthly
0.5
2025-02-25
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-5ejxt
monthly
0.5
2025-02-25
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-pdxn8-g3tlb-dbz92
monthly
0.5
2025-02-17
https://www.7hillspharma.com/news-publications/urvv9pwo644estbsdjufiqn0b3vqmu
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/w1mheqe1ht3410vjtbrinkur1piv80
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/7qz3kojqysrkyek764ar2pfm2wd6aw
monthly
0.5
2025-02-26
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-s8fhn-28ded
monthly
0.5
2025-02-10
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-pdxn8-g3tlb-dbz92-6sepm
monthly
0.5
2025-02-17
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-5ejxt-mh6h4-h9jx9
monthly
0.5
2025-02-18
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-pdxn8
monthly
0.5
2025-02-10
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-pdxn8-g3tlb
monthly
0.5
2025-02-10
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-s8fhn
monthly
0.5
2025-02-10
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy
monthly
0.5
2025-02-10
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-s8fhn-sfj5w
monthly
0.5
2025-02-18
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-pdxn8-g3tlb-dbz92-lxkga
monthly
0.5
2025-02-17
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-d52l9
monthly
0.5
2025-02-10
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6
monthly
0.5
2025-02-10
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-xwbtx
monthly
0.5
2025-02-10
https://www.7hillspharma.com/news-publications/5q4w5fr9bu6jetckdoqxrylyschxh6-9abcy-s8fhn-28ded-asb9x
monthly
0.5
2025-02-18
https://www.7hillspharma.com/news-publications/category/Role+of+Integrins+in+T+Cell+Activation
monthly
0.5
https://www.7hillspharma.com/news-publications/category/7+Hills+Integrin+Activators
monthly
0.5
https://www.7hillspharma.com/news-publications/category/Publications
monthly
0.5
https://www.7hillspharma.com/news-publications/category/News
monthly
0.5
https://www.7hillspharma.com/news-publications/category/Role+of+Integrins+in+Tumor+Immune+Surveillance
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Leadership
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+cell+activation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Funding
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Enhancing+vaccine+efficacy+with+7HP349
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Cancer+immunotherapy+challenges
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Tumor+endothelium+and+immune+evasion
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrins+in+tumor+microenvironment
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/ICAM-1+and+T+cell+adhesion
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Systemic+immune+stimulation+in+cancer+therapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Enhancing+T+cell+infiltration+in+tumors
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immuno-oncology
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Clinical+Trials
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immune+cell+recruitment+in+hepatocellular+carcinoma
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+Lymphocyte+Regulation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/CD137+mAb+immunotherapy+mechanism
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Link+between+immune+suppression+and+tumor+growth
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immune+cell+trafficking+in+tumors
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/THI0019+small+molecule+agonist
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/BARDA+collaboration
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/immune+system
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Leukocyte+infiltration+in+tumors
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Enhancing+immune+cell+infiltration
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/LFA-1+activation+cancer+therapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Scientific+Advisory+Board
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/melanoma
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immunological+synapse+stability
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Antigen-specific+Immune+Responses
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrin+Activation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Cell+adhesion+molecules+in+cancer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/7HP349+and+cancer+treatment
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+Cell+Activation+Inhibition
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/NF-AT+and+NF-kappa+B+Activation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+cell-APC+interactions
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Enhancing+TIL+infiltration+in+tumors
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Dendritic+Cell+Interaction+with+CD8%2B+T+Cells
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Market+Exclusivity
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+Cell+Costimulation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+cell+homing+blockade+in+cancer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/7HP349+immune+activation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Biotechnology
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/FDA
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/ICAM-1+and+T+Cell+Priming
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Endothelial+adhesion+molecules+in+cancer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+cell+activation+adjuvant
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Oncology
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/7HP349+immunotherapy+enhancer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Fast+Track+Designation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/cancer+research
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/SBIR+grant
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/7HP349+immune+system+booster
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Alpha4+Integrin+Antagonist
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/cell+adhesion
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Checkpoint+inhibitors+and+integrin+activators
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Enhancing+immune+checkpoint+blockade
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immune+Cell+Signaling
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/NIAID+grant
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+cell+infiltration+in+immunotherapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrin+modulation+in+immunotherapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/BARDA+Funding
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/University+of+Texas+Medical+Branch
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Alpha+4+Beta+1+Integrin
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrin+activators+in+cancer+therapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/VLA-4+integrin+activation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Hematopoietic+stem+cell+engraftment
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrins+as+targets+for+cancer+immunotherapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immune+Activators
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immune+Cell+Adhesion
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/7HP349+vaccine+adjuvant
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/NK+cell+recruitment+in+cancer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/NCI-funded
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Cancer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/immuno-oncology+drug+enhancement
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrin+activator+tumor+immunity
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immune+Memory+Formation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/LFA-1+ICAM-1+signaling
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Cancer+vaccine+T+cell+trafficking
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/integrin+activator+immunotherapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Endothelial+adhesion+molecules+in+tumors
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/integrin+activator
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Tumor+microenvironment+and+immune+evasion
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Pharmaceutical+Policy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immunotherapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/oral+immunostimulant
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+cell+activation+mechanisms
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Systemic+adjuvant+for+vaccines
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/immune+Response
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Angiogenesis+and+immunosuppression+in+cancer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/clinical+trial
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/CTLA-4+blockade+synergy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Cancer+immunotherapy+and+blood+vessel+formation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Gene+Therapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/ICAM-1+expression+in+cancer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Tumor-specific+CD8%2B+T+cells+activation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Stem+cell+adhesion+therapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Chief+Medical+Officer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Tumor+immune+evasion+mechanisms
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrin+Targeted+Therapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Anti-PD-1-resistant
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Tumor-infiltrating+lymphocytes+in+HCC
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/checkpoint+inhibitors
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/ICAM-1+and+antigen-presenting+cells
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Drug+Repurposing
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/CD137+agonist+antibodies+in+cancer+therapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/COVID-19+Treatments
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Cytotoxic+T+Lymphocyte+Activation
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/ICAM-1+and+VCAM-1+in+cancer+treatment
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immunotherapy+and+cancer+vaccines
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/integrin+agonists
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrin+activators+for+vaccines
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Intellectual+Property
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Angiogenic+factors+and+tumor+immunity
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/integrin+activators
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Tumor+endothelial+cells+and+T+cell+recruitment
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrin-targeted+stem+cell+therapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Integrin+activator+immune+response
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Multiphoton+Imaging+of+Immune+Responses
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Vascular+Adhesion+Protein-1+in+cancer
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Endothelial+adhesion+molecules+in+malignancies
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T+cell+infiltration+cold+tumors
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Patents
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/CPRIT+Grants
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Lionel+D.+Lewis+CMO
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Cancer+immunotherapy+strategies
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Cytokine+Induction+in+T+Cells
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Chagas
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Endothelin+B+receptor+and+tumor+immunity
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Enhancing+T-cell+trafficking+for+immunotherapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/7+Hills+Pharma+immunotherapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Vaccine
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Leukocyte+recruitment+in+tumors
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/T-cell+infiltration+in+tumors
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/NIH-Funded
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Peptide-based+cancer+vaccine+strategies
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/7HP349
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/ICAM-1+and+cancer+immunotherapy
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Texas+Heart+Institute
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Pharma
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Angiogenesis+inhibitors+and+immune+response
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/VLA-4+and+LFA-1+in+tumor+immunity
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Immune+system+and+cancer+relationship
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Enhancing+progenitor+cell+retention
monthly
0.5
https://www.7hillspharma.com/news-publications/tag/Chagas+disease+vaccine+booster
monthly
0.5
https://www.7hillspharma.com/contact
daily
0.75
2025-04-03
https://www.7hillspharma.com/home
daily
1.0
2025-03-28
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/1831a228-bade-4883-a0fb-8709eb5f6e99/7HP-patient-diversity-v2.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/4da17a6b-4a5a-4234-9b6c-45447d31b0e2/7hp-hill-2-l-orange-144.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/7764d781-fff2-4ea8-b215-a5f02955ebc3/7hp-t-cell-2.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/c836bc2c-64c9-4363-9624-31e79a73ffea/tumor-cell.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/274f4c18-8ca7-47d3-a123-d94b41cb7fe2/7hp-t-cell-1.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/7764d781-fff2-4ea8-b215-a5f02955ebc3/7hp-t-cell-2.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/274f4c18-8ca7-47d3-a123-d94b41cb7fe2/7hp-t-cell-1.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/a8059a79-1da2-4039-bbd3-0b6311b615ea/stem-cell-neurtophil-platelets-v3.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/ad1a8bee-d13d-4b3a-8aa8-4b9df49fa972/7hp-pipeline-v2-144-v2.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e2a41924-529f-4c80-8d4b-11e2e67a7fad/7HP-Team-Photo-4-transparent.png
https://www.7hillspharma.com/about
daily
0.75
2025-02-26
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/1831a228-bade-4883-a0fb-8709eb5f6e99/7HP-patient-diversity-v2.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/71955d4c-1663-4859-b5b7-6bf7ba456e52/7hp-hill-2-r-orange-144.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/39af23be-aa40-40a9-a0c7-0acac1eecbf9/AdobeStock_608119106.jpeg
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/a08edbaa-4c7d-4118-b53c-04ffb697a3ff/7hp-hill-1-l-yellow-144.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/36b647af-9d37-4309-b38f-d28f0f6bf581/The-Texas-Heart-Institute-Baylor-St.-Lukes-Medical-Center-Day_Credit-Texas-Heart-Institute.jpg
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/9d5eb16b-f8da-4dcf-92da-3c63fbf923ea/thi-logo.jpg
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/be3738cc-b4e9-44e7-9802-fe610eddf797/7hp-alintegomid-v1.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/a08edbaa-4c7d-4118-b53c-04ffb697a3ff/7hp-hill-1-l-yellow-144.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/29985a43-dcbd-40ba-917b-b86136b63e6a/7hp-stem-cell.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/29985a43-dcbd-40ba-917b-b86136b63e6a/7hp-stem-cell.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/29985a43-dcbd-40ba-917b-b86136b63e6a/7hp-stem-cell.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/71955d4c-1663-4859-b5b7-6bf7ba456e52/7hp-hill-2-r-orange-144.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/58f171a5-6fb7-43f6-a6e1-7c56fb42a1df/Amazing-Golden-Gopuram-Of-The-Tirumala-Temple-v2.jpg
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e2a41924-529f-4c80-8d4b-11e2e67a7fad/7HP-Team-Photo-4-transparent.png
https://www.7hillspharma.com/leadership
daily
0.75
2025-04-03
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/88c3f570-d5d8-4c47-9913-394ba9133ac1/Headshot---UKM.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/bda534c3-7083-49bf-9079-ddc23a662fbd/Headshot---LDL.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/1d336928-69ae-403d-adc8-dba4486476e4/Headshot---RSB.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/08d4e235-af42-4c42-b3c8-94152ba2e434/Headshot---william.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/2acf336f-c223-4bb5-ad2d-28c8842f86e9/Headshot---Siddhartha.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/3b0f883e-e70d-4623-ac92-269d613db29a/Headshot---Nicole.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/281b8cd5-34f8-46be-8178-0bd4630bd45b/Headshot---Nada.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/80b135d1-c46a-4050-9624-d4476033f351/Headshot---Nancy.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/df9420ee-4dc6-47bf-9ecb-3cde3edd833a/Headshot---Joe.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/59ae6319-a9d5-4bed-bd46-a24aa811e828/Headshot---SAB-v2.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/bdb2864c-02c7-4af8-9a2f-f6fcc25ccc31/Headshot---Kala.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/88c3f570-d5d8-4c47-9913-394ba9133ac1/Headshot---UKM.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/2a46c7e7-14dc-4207-8cee-6f5e2cafd4fe/Headshot---Darren.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/08f8b365-6677-4491-aff6-2f479922859a/Headshot---Peter.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/15aa82a6-91c9-44ea-81ff-662f87736711/Headshot---jeff.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/225806d9-d89d-4c94-a83b-d4fa317456f0/Headshot---Mary.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/b911f958-97b8-4d8b-8edf-d349a4c92647/Headshot---Kramer.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/95457ff3-09e3-4f65-889a-8a9c1ca7e678/Headshot---Mike.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/e7f69ece-fbd9-4b5d-a4a6-104f338f3820/linkedin-icon-512x512.png
https://www.7hillspharma.com/technology
daily
0.75
2025-05-01
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/ad1a8bee-d13d-4b3a-8aa8-4b9df49fa972/7hp-pipeline-v2-144-v2.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/4da17a6b-4a5a-4234-9b6c-45447d31b0e2/7hp-hill-2-l-orange-144.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/7764d781-fff2-4ea8-b215-a5f02955ebc3/7hp-t-cell-2.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/c836bc2c-64c9-4363-9624-31e79a73ffea/tumor-cell.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/274f4c18-8ca7-47d3-a123-d94b41cb7fe2/7hp-t-cell-1.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/7764d781-fff2-4ea8-b215-a5f02955ebc3/7hp-t-cell-2.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/274f4c18-8ca7-47d3-a123-d94b41cb7fe2/7hp-t-cell-1.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/06a4554d-30e2-4321-b9ff-5e07ea4a38ed/Cancer+Immunity+Cycle-w-key-2025.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/fcfee084-aef5-44d4-9b0f-02ccb1239537/7hp-patients-evidence.jpg
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/4da17a6b-4a5a-4234-9b6c-45447d31b0e2/7hp-hill-2-l-orange-144.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/71955d4c-1663-4859-b5b7-6bf7ba456e52/7hp-hill-2-r-orange-144.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/cb87e957-4032-43c6-b008-b4d69156427c/7hp-patient-infusion.jpg
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/30b29f08-a459-47c8-be80-b81d6c5bcd21/7hp-alintegomid-v1.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/a08edbaa-4c7d-4118-b53c-04ffb697a3ff/7hp-hill-1-l-yellow-144.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/29985a43-dcbd-40ba-917b-b86136b63e6a/7hp-stem-cell.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/29985a43-dcbd-40ba-917b-b86136b63e6a/7hp-stem-cell.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/29985a43-dcbd-40ba-917b-b86136b63e6a/7hp-stem-cell.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/29985a43-dcbd-40ba-917b-b86136b63e6a/7hp-stem-cell.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/a8059a79-1da2-4039-bbd3-0b6311b615ea/stem-cell-neurtophil-platelets-v3.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/4208b558-c7c4-4211-8c76-39a3b81c1fd9/Stem-Cell-Delivery-to-Bone-Marrow-Websafe.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/ea702ec9-d6f8-4493-a42d-c8e9e21812ed/7hp-dna-crispr.png
https://images.squarespace-cdn.com/content/v1/6671a3065227c71ef428a029/1740164976982-QEBLG3J30Z57MYF5EZ39/unsplash-image-Oj77q2yIjzI.jpg